Cancer Advisor

Most people imagine cancer prevention as something slow, complicated, and highly disciplined: Clean diets. Gym routines. Supplements. Perfect consistency. That’s not how it usually works in real life. The most sustainable strategies are almost invisible. They take seconds—not hours. And two of the most powerful tools are: Habit stacking ( emphasized by the American Institute for Cancer Research -  AICR ) VILPA (Very Intense Light Physical Activity) ( JAMA Oncology ) Used together, they quietly reshape cancer risk over time. The Problem: Willpower Fails. Systems Don’t. Cancer risk is shaped over years—not days. Yet most prevention advice fails because it relies on: motivation memory lifestyle overhauls “starting Monday” energy That’s not how human behavior works. A more effective approach is simple: Attach tiny cancer-protective actions to things you already do every day. This is called habit stacking , a concept widely used in behavior change science and popularized in ...

Cancer treatment is undergoing a major shift. For decades, radiotherapy was viewed mainly as a local treatment used to destroy tumors in a targeted area. Immunotherapy, meanwhile, emerged as a systemic therapy capable of activating the body’s immune system against cancer. Now, researchers are discovering something remarkable: Radiotherapy and immunotherapy may work far better together than either treatment alone. This combination is reshaping oncology by turning radiation into more than just a tumor-killing tool. In some patients, radiation may help “teach” the immune system to recognize and attack cancer throughout the body. A landmark review published in Nature Signal Transduction and Targeted Therapy explored how this synergy could transform cancer care. Why Combining Radiotherapy and Immunotherapy Matters Traditional radiotherapy works by damaging tumor DNA. However, scientists now know radiation also: releases tumor antigens, activates immune signaling, stimulates dendritic cells...

OZONE, MELATONIN, CBD OIL Testimonial (1) - 42 year old Italian woman with Stage 4 Triple Negative Breast Cancer achieves COMPLETE REMISSION! Italian researchers are doing some serious Cancer Research, and are at least a decade ahead of every big Cancer Center in America. STORY: 42 year old woman was diagnosed with Stage 1 Breast Cancer Triple Negative (TNBC) in 2017 and had surgery, chemo and radiation. She was found to have BRCA1 mutation. In 2019 she was diagnosed with Stage 4 Breast TNBC Lung and mediastinal lymph node metastases. (perfect example of failure of modern Oncology) Sep.2019 she started: Chemo (carboplatin and gemcitabine, stopped in Nov.2019 due to side effects (sorry chemo enthusiasts) Integrative Protocol: Melatonin, CBD, Ozone Therapy: Ozone (Rectal) : 80ug/mL, 2.5ml/kg, 4 times per week for 3 months, followed by a 3 month break Melatonin, starting at 100mg/day and increasing the dose by 100mg every 3 days up to 2000mg/day (500mg tablets, 4 per day) C...

For decades, chemotherapy was the backbone of cancer treatment. While chemotherapy can still save lives, a major shift is happening in oncology: immunotherapy is increasingly replacing — or dramatically reducing — the need for chemotherapy in selected cancers. Checkpoint inhibitors, CAR-T therapies, bispecific antibodies, tumor vaccines and precision immunotherapy combinations are changing survival outcomes once considered impossible. In some cancers, chemotherapy-free treatment is already becoming a new standard of care. Here are 10 cancers where immunotherapy is reshaping the future of treatment. 1. Melanoma Few cancers demonstrate the power of immunotherapy better than melanoma. Before checkpoint inhibitors, metastatic melanoma had extremely poor survival rates. Today, drugs targeting PD-1 and CTLA-4 have transformed outcomes for many patients. Examples include: Pembrolizumab Nivolumab Ipilimumab In many advanced melanoma cases: Immunotherapy is preferred before chemotherapy Durable...

A balanced, evidence-informed guide for cancer patients and caregivers exploring ivermectin as a repurposed therapy — what the research shows, what it doesn't, and how to proceed safely. Contents Who Is Dr. William Makis? How Ivermectin May Work Against Cancer The Core Protocols (2025–2026) What the Research Actually Shows Reported Patient Outcomes Risks, Side Effects & Drug Interactions How to Access Ivermectin Safely Frequently Asked Questions Key Takeaways Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Ivermectin used in cancer care is off-label and investigational. The evidence base is still developing. Do not start, stop, or change any treatment without guidance from a licensed physician who knows your full medical history. Individual outcomes vary significantly. 1. Who Is Dr. William Makis? Dr. William Makis is a Canadian-trained physician with a background in nuclear medicine and radiology (McGill University, 11...